Introduction
ErbB3, also known as HER3 (human epidermal growth factor receptor 3), belongs to the ErbB family of tyrosine kinase receptors. This family is known for its role in receiving signals from epidermal growth factor (EGF) family growth factors. Uniquely, ErbB3 possesses a kinase domain that is defective. This receptor is found in various cells, including keratinocytes, melanocytes, skeletal muscle cells, embryonic myoblasts, and Schwann cells. While ErbB3 alone acts as a low-affinity receptor for heregulins (HRG), it can trigger a specific antibody response in living organisms, potentially suppressing tumor cell growth. ErbB-3 shows promise in treating breast cancer at various stages (early, medium, advanced, or post-operative) where ErbB2 is overexpressed. Due to its mode of action, ErbB3 is categorized as a therapeutic agent for cancer.
Description
Recombinant Human Tyrosine Kinase ErbB3 (HER3) is produced in E. coli. This non-glycosylated polypeptide is a single chain comprising several epitopes from the extracellular domain of human Erb-b3. Its total molecular weight is approximately 12.0 kDa. The purification of ErbB3 is achieved using specialized chromatographic techniques.
Physical Appearance
White, semi-transparent suspension with a concentration of 1 mg/ml.
Formulation
Each milligram of protein contains: 1 mg aluminum hydroxide, 10 mM arginine, 10 mM sodium chloride, 20 mM sodium phosphate buffer, and 5 mM potassium phosphate. To create a stock solution, it is recommended to dilute the contents of the vial with sterile phosphate-buffered saline containing 1 mg aluminum hydroxide.
Stability
ErbB3 remains stable at 4°C for one week. However, for optimal storage, it is recommended to keep it below -18°C. To ensure long-term stability, consider adding a carrier protein (0.1% HSA or BSA). Avoid repeated freezing and thawing.
Purity
Exceeds 95.0% purity, as determined by: (a) Reverse-phase high-performance liquid chromatography (RP-HPLC) analysis. (b) Sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis.
Biological Activity
Evaluated based on its ability to delay tumor onset in FVB/N transgenic mice predisposed to spontaneous breast cancer. It effectively inhibits both the development of these tumors and the growth of in situ transplanted breast cancer in the same mouse model.
Synonyms
Receptor tyrosine-protein kinase erbB-3, EC 2.7.10.1, c-erbB3, Tyrosine kinase-type cell surface receptor HER3, ErbB3, HER3.